MAIA Biotechnology, Inc. is a specialized immuno-oncology company dedicated to researching, developing, and commercializing groundbreaking pharmaceuticals to enhance and prolong the lives of individuals battling cancer. With a focus on innovation, MAIA is at the forefront of pioneering therapies with novel mechanisms of action.
GivBux, Inc. has unveiled a groundbreaking Super App after four years of development, merging brands, consumers, and charities into a unified economic ecosystem. This innovative platform offers retailers new business avenues, rewards for consumers, and promotes charitable contributions effortlessly.
Generated from the website